Success Stories: NIW Petition Approved for a Researcher from Togo in the Field of Nutrition Without Any Request for Evidence [RFE], Thanks to Our Team’s Dedication and Guidance

Client’s Testimonial:

“I appreciated the work you did, especially the promptness with which you responded. Thank you so much for your kind words and support throughout the process. I’m thrilled to have my I-140 NIW approved, and I truly appreciate your expertise and guidance.”

On March 6^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Nutrition (Approval Notice).

General Field: Nutrition

Position at the Time of Case Filing: Researcher

Country of Origin: Togo

State of Residence at the Time of Filing: Togo

Approval Notice Date: March 6^th, 2025

Processing Time: 9 months, 20 days

Case Summary:

Based on the huge number of successful cases, North America Immigration Law Group has developed the most up-to-date winning strategies for the NIW category, which enable us to offer our “Approval or Refund” services to many of the NIW cases we take. However, there are certain prerequisites to be fulfilled by an individual, including:

The foreign national must be in a position to advance the proposed endeavor.
The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.
A proposed endeavor, holding substantial merit and national importance.

Our client, a researcher from Togo, approached us to file an NIW (National Interest Waiver Petition) on her behalf.

She has completed her M.S. in developmental biology, and as an expert in the field of nutrition, her proposed endeavor is to develop approaches for characterizing the bioactive molecules in non-timber forest products that influence gene expression to explore the therapeutic applications of these products in diet-related chronic pathologies.

Therefore, to make a persuasive case in her favor, we included the following details in her petition packet:

Her work has resulted in 12 peer-reviewed journal articles (9 of them first-authored) and 1 first-authored peer-reviewed conference article.
Her publications have been cited a total of 65 times, according to Google Scholar.
She has even received 2 recommendation letters from fellow experts in her field of expertise. Out of those, one of the excerpts is mentioned below:

“…[Client] is a leading nutrition researcher, renowned for her pioneering work on edible insects as a sustainable food source. Her research, published in prestigious journals, demonstrates continuous benefits to the United States by tackling food security and environmental sustainability. Her innovative solutions contribute significantly to the field, making her an indispensable figure in advancing nutrition science and promoting global well-being.”

While these specific research contributions represent only a subset of our client’s most successful endeavors, these projects are indicative of the overall quality of her research and illustrate her particular expertise and ability to continue contributing significantly to her field and to advancing the proposed endeavor.

Her research has also been supported with funding from the International Foundation for Science. This funding supports projects that advance global science towards sustainable development. Therefore, our client’s research supports the exploration of sustainable food sources.

On that account, she received her NIW approval despite waiting for a longer period, but without any request for evidence [RFE]. We wish her good luck in her upcoming endeavor.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.